System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Nicolas Penel is an expert in Oncology at Centre Oscar Lambret (France). As of October 2026, ScienceLeadR ranks Nicolas Penel in the top 1% of experts worldwide for Sarcoma. Nicolas Penel has authored 789 publications, the most recent in 2026, and is an investigator in 70 clinical trials, 7 of them ongoing. SLR score: 3,687 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Nicolas Penel Centre Oscar Lambret France
3 687 ScienceLeadR Reputation 3687

Unlock

Register Login
Network Map

Oncology

Subspecialties: Pharmacy - Gynecology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026
Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 789

Citations

Citations: 24 637 1st author: 136 Last author: 130 Unique author: 17

Main journals

J Clin Oncol 155
Ann Oncol 128
Bull Cancer 73
Eur J Cancer 44
Lancet Oncol 21

Best Journals

Ann Oncol 54
J Clin Oncol 44
Lancet Oncol 21

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Insights into rhabdomyosarcoma in the adolescent and young adult population: a comprehensive clinical study from the French Society of Pediatric Oncology (SFCE) Malignant Mesenchymal Tumor (MMT) Committee and the French Sarcoma Group (GSF-GETO).
PMID 42735453 — rhabdomyosarcoma, neoplasms, drug therapy, sarcoma, aged, adolescent, therapeutics, prognosis, chemotherapy		ESMO Open20260
Head & Neck and Shoulder Desmoid-Type Fibromatosis: Presentation and Natural History of These Ultra-Rare Locations.
PMID 42905937 — fibromatosis, aggressive, natural history, pain, neoplasms, history		Cancer Med20260
Molecular profiling and access to treatment for rare cancers in Europe.
PMID 42642364 — biological science disciplines, neoplasms, therapeutics		Nat Commun20260
Deni Study: Real-World Data on the Use of Nirogacestat in Patients With Desmoid Tumors in the French Sarcoma Group.
PMID 42522292 — fibromatosis, aggressive, pain, neoplasms, sarcoma, fatigue, drug tapering, therapeutics		Int J Cancer20260
Fat mass and survival in immunotherapy-treated metastatic renal cell carcinoma patients.
PMID 42461914 — cells, muscles, neoplasms, carcinoma, renal cell, biomarkers, immunotherapy, therapeutics		Oncology20260

Clinical Studies 70

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 13 Study Chair: 2 Study Director: 3

By phase:

Phase 2 34
N/A 15
Phase 3 11
Phase 1 7
Phase 2/Phase 3 3

By status:

Completed 44
Recruiting 11
Active not recruiting 7
Terminated 5
Unknown 3

By type:

Interventional 64
Observational 6

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 5
multicentric5to9 9
multicentricup10 46

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A clinical study of ABSK021 in Patients with Tenosynovial Giant Cell Tumor to determine whether the study drug is safe and how well the antitumor activity of study drug
2023-503245-58-00 — cells, safety, pharmaceutical preparations, giant cell tumors, giant cell tumor of tendon sheath, neoplasms, giant cells		Phase 3Active not recruiting2023
Assessment of Cancer related Post traumatic Stress in Patients and Caregivers in the Year Following Diagnosis and Identification of Their Expectations of Personalized Support CANDYSTRESS
NCT06944262 — stress disorders, post-traumatic, caregivers, stress, physiological, neoplasms, signs and symptoms, stress disorders, traumatic, diagnosis, wounds and injuries		N/ARecruiting2025
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
NCT06408441 — registries, natural history, hemangioendothelioma, neoplasms, sarcoma, diagnosis, therapeutics, history, physical exertion, tissues, hemangioendothelioma, epithelioid		N/ARecruiting2023
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
NCT05500391 — nurses, cells, fibromatosis, aggressive, sex cord-gonadal stromal tumors, glioma, monitoring, ambulatory, gastrointestinal stromal tumors, adenocarcinoma, clear cell, adenocarcinoma, mucinous, ovary, neoplasms, adenocarcinoma, carcinoma, small cell, physicians, germ cells, carcinosarcoma, sex, neuroendocrine tumors, seminoma, carcinoma		Phase 2Recruiting2024
Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)
NCT04921553 — registries, genes, quality of life, data collection, proto-oncogene proteins c-sis, neoplasms, gene rearrangement, gene fusion, therapeutics, mutation		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS